{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:52:32Z","timestamp":1791384752652,"version":"4.3.3"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":270,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fareon, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cognitive impairment is common in post-acute sequelae of severe acute respiratory syndrome coronavirus 2 infection (long COVID) and substantially affects function and quality of life. Evidence suggests that sustained neuroinflammation, cerebrovascular dysfunction and mitochondrial impairment contribute to cognitive symptoms. Microtesla Magnetic Therapy (MMT) is a transcranial, low-amplitude radiofrequency magnetic field intervention that has shown anti-inflammatory and neuroprotective effects in preclinical models, suggesting potential value in long COVID and other neurological disorders. This is the first randomized controlled trial of MMT for long COVID cognitive impairment. We evaluated the feasibility (primary) and safety (secondary) of at-home MMT in individuals with objective cognitive impairment from long COVID. Thirty participants were randomized 2:1 to active or sham MMT and self-administered 15-min treatments at home twice weekly for 4 weeks, with remote monitoring, using a head-worn device delivering a non-thermal radiofrequency magnetic field to the whole brain. Feasibility was defined as completing at least 80% of prescribed treatments and all study visits. Safety was assessed by adverse events. Cognitive function and self-reported mood and quality of life were exploratory outcomes assessed at baseline, Week 4 (post-treatment) and Week 8 (follow-up). Feasibility was high: all participants who completed the study adhered to 100% of treatments, and usability ratings were strong. No device-related adverse events occurred. Compared with sham, active MMT participants showed significantly greater improvement from baseline to Week 8 in Wechsler Adult Intelligence Scale Digit Span Sequencing (P = 0.026), Hopkins Verbal Learning Test\u2013Revised Total Recall (P = 0.044) and Delis-Kaplan Executive Function System Color Naming (P = 0.049). Other measures of attention, processing speed and executive function did not differ significantly between groups. Emotional well-being on the 36-Item Short Form Survey improved significantly more with active MMT at Week 8 (P = 0.017). Depression and anxiety decreased in both groups; the anxiety reduction was greater with active treatment in the linear mixed-effects model (week \u00d7 treatment interaction, P = 0.038) but not in the between-group change score comparison (P = 0.057). At-home MMT was feasible, safe and well tolerated in individuals with cognitive impairment from long COVID. These preliminary, exploratory findings showed nominally significant between-group differences favouring active treatment on selected cognitive measures and emotional well-being and require confirmation in larger, adequately powered trials.<\/jats:p>","DOI":"10.1093\/braincomms\/fcag364","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:25:07Z","timestamp":1790425507000},"source":"Crossref","is-referenced-by-count":0,"title":["Microtesla magnetic therapy for cognitive impairment in long COVID: a randomized pilot study"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-8704","authenticated-orcid":false,"given":"Alexandra","family":"Canori","sequence":"first","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanshi","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Santiago","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maltz","sequence":"additional","affiliation":[{"name":"Fareon, Inc. , San Francisco, CA 94107 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gurfein","sequence":"additional","affiliation":[{"name":"Fareon, Inc. , San Francisco, CA 94107 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putrino","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-6046","authenticated-orcid":false,"given":"Jacqueline","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"6","key":"2026100710014733800_fcag364-B1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/cid\/ciaf046","article-title":"Long COVID incidence proportion in adults and children between 2020 and 2024: An electronic health record-based study from the RECOVER initiative","volume":"80","author":"Mandel","year":"2025","journal-title":"Clin Infect Dis."},{"key":"2026100710014733800_fcag364-B2","volume-title":"A long COVID definition: A chronic, systemic disease state with profound consequences","author":"Goldowitz","year":"2024"},{"issue":"6","key":"2026100710014733800_fcag364-B3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15585\/mmwr.mm7306a4","article-title":"Notes from the field: Long COVID prevalence among adults\u2014United States, 2022","volume":"73","author":"Ford","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2026100710014733800_fcag364-B4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat Immunol"},{"issue":"4","key":"2026100710014733800_fcag364-B5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1473-3099(23)00053-1","article-title":"Why we need a deeper understanding of the pathophysiology of long COVID","volume":"23","author":"Iwasaki","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2026100710014733800_fcag364-B6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2026100710014733800_fcag364-B7","doi-asserted-by":"crossref","first-page":"e221809","DOI":"10.1001\/jamahealthforum.2022.1809","article-title":"The costs of long COVID","volume":"3","author":"Cutler","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"1","key":"2026100710014733800_fcag364-B8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s43856-025-00759-0","article-title":"A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States","volume":"5","author":"Kim","year":"2025","journal-title":"Commun Med (Lond)."},{"key":"2026100710014733800_fcag364-B9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"10","key":"2026100710014733800_fcag364-B10","doi-asserted-by":"crossref","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","article-title":"Assessment of cognitive function in patients after COVID-19 infection","volume":"4","author":"Becker","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026100710014733800_fcag364-B11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbi.2024.04.015","article-title":"Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures","volume":"119","author":"VanElzakker","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"14","key":"2026100710014733800_fcag364-B12","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","article-title":"Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation","volume":"185","author":"Fern\u00e1ndez-Casta\u00f1eda","year":"2022","journal-title":"Cell"},{"key":"2026100710014733800_fcag364-B13","doi-asserted-by":"crossref","first-page":"e930886","DOI":"10.12659\/MSM.930886","article-title":"Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce \u201cbrain fog\u201d and results in behavioral changes that favor viral survival","volume":"27","author":"Stefano","year":"2021","journal-title":"Med Sci Monit"},{"issue":"8","key":"2026100710014733800_fcag364-B14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamapsychiatry.2023.1321","article-title":"Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms","volume":"80","author":"Braga","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2026100710014733800_fcag364-B15","doi-asserted-by":"publisher","author":"Visser","DOI":"10.1101\/2022.06.02.22275916"},{"key":"2026100710014733800_fcag364-B16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2023.08.014","article-title":"Greater executive dysfunction in patients post-COVID-19 compared to those not infected","volume":"114","author":"Becker","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2026100710014733800_fcag364-B17","doi-asserted-by":"crossref","first-page":"101093","DOI":"10.1016\/j.bbih.2025.101093","article-title":"Neurocognitive trajectories in long COVID: Evidence from longitudinal analyses","volume":"48","author":"Becker","year":"2025","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"2026100710014733800_fcag364-B18","doi-asserted-by":"crossref","first-page":"808e","DOI":"10.1097\/PRS.0000000000001152","article-title":"Pulsed electromagnetic fields reduce postoperative interleukin-1\u03b2, pain, and inflammation: A double-blind, placebo-controlled study in TRAM flap breast reconstruction patients","volume":"135","author":"Rohde","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2026100710014733800_fcag364-B19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2012.03.089","article-title":"Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury","volume":"519","author":"Rasouli","year":"2012","journal-title":"Neurosci Lett"},{"issue":"1","key":"2026100710014733800_fcag364-B20","doi-asserted-by":"crossref","first-page":"114425","DOI":"10.1016\/j.isci.2025.114425","article-title":"Transcranial microtesla magnetic fields suppress neuroinflammation and neuronal oxidative stress burden","volume":"29","author":"Nguyen","year":"2026","journal-title":"iScience"},{"key":"2026100710014733800_fcag364-B21","doi-asserted-by":"crossref","first-page":"101393","DOI":"10.1016\/j.conctc.2024.101393","article-title":"A simple blinding index for randomized controlled trials","volume":"42","author":"Petroff","year":"2024","journal-title":"Contemp Clin Trials Commun"},{"key":"2026100710014733800_fcag364-B22","volume-title":"Wechsler adult intelligence scale","author":"Wechsler","year":"2008","edition":"4th ed"},{"issue":"1","key":"2026100710014733800_fcag364-B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","article-title":"Hopkins verbal learning test\u2014Revised: Normative data and analysis of inter-form and test-retest reliability","volume":"12","author":"Benedict","year":"1998","journal-title":"Clin Neuropsychol"},{"key":"2026100710014733800_fcag364-B24","volume-title":"Delis-Kaplan executive function system (D-KEFS) examiner\u2019s manual","author":"Delis","year":"2001"},{"key":"2026100710014733800_fcag364-B25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills."},{"key":"2026100710014733800_fcag364-B26","volume-title":"Ruff 2 & 7 selective attention test: Professional manual","author":"Ruff","year":"1996"},{"key":"2026100710014733800_fcag364-B27","volume-title":"Brief visuospatial memory test\u2014Revised: Professional manual","author":"Benedict","year":"1997"},{"key":"2026100710014733800_fcag364-B28","volume-title":"Rey Complex figure test and recognition trial: Professional manual","author":"Meyers","year":"1995"},{"key":"2026100710014733800_fcag364-B29","volume-title":"Symbol digit modalities test (SDMT) manual (revised)","author":"Smith","year":"1982"},{"issue":"3","key":"2026100710014733800_fcag364-B30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1017\/S1366728911000332","article-title":"Self-ratings of spoken language dominance: A Multilingual Naming Test (MINT) and preliminary norms for young and aging Spanish-English bilinguals","volume":"15","author":"Gollan","year":"2012","journal-title":"Biling: Lang Cogn"},{"issue":"9","key":"2026100710014733800_fcag364-B31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2026100710014733800_fcag364-B32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"2026100710014733800_fcag364-B33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/diagnostics8030066","article-title":"A brief questionnaire to assess post-exertional malaise","volume":"8","author":"Cotler","year":"2018","journal-title":"Diagnostics"},{"issue":"11","key":"2026100710014733800_fcag364-B34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2026100710014733800_fcag364-B35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"5","key":"2026100710014733800_fcag364-B36","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/alz.13770","article-title":"Minimal clinically important difference in Alzheimer\u2019s disease: Rapid review","volume":"20","author":"Muir","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"issue":"10","key":"2026100710014733800_fcag364-B37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1017\/S0033291720003700","article-title":"How much change is enough? Evidence from a longitudinal study on depression in UK primary care","volume":"52","author":"Kounali","year":"2022","journal-title":"Psychol Med"},{"issue":"5","key":"2026100710014733800_fcag364-B38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/09602011.2025.2552154","article-title":"Preliminary evaluation of a cognitive rehabilitation intervention for post-COVID-19 cognitive impairment: A pilot randomized controlled trial","volume":"36","author":"Becker","year":"2025","journal-title":"Neuropsychol Rehabil"},{"issue":"1","key":"2026100710014733800_fcag364-B39","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1038\/s41598-022-15565-0","article-title":"Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial","volume":"12","author":"Zilberman-Itskovich","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2026100710014733800_fcag364-B40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jamaneurol.2025.4415","article-title":"Evaluation of interventions for cognitive symptoms in long COVID: A randomized clinical trial","volume":"83","author":"Knopman","year":"2026","journal-title":"JAMA Neurol"},{"issue":"1","key":"2026100710014733800_fcag364-B41","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1038\/s41598-023-32939-0","article-title":"Cognitive impairment in young adults with post COVID-19 syndrome","volume":"13","author":"Herrera","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"2026100710014733800_fcag364-B42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/joim.13720","article-title":"Cognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation","volume":"294","author":"M\u00f6ller","year":"2023","journal-title":"J Intern Med"},{"issue":"8","key":"2026100710014733800_fcag364-B43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14740\/jmc4254","article-title":"Methylphenidate for the treatment of post-COVID cognitive dysfunction (brain fog)","volume":"15","author":"Clark","year":"2024","journal-title":"J Med Cases"},{"key":"2026100710014733800_fcag364-B44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jocn.2023.09.005","article-title":"The effect of donepezil hydrochloride on post-COVID memory impairment: A randomized controlled trial","volume":"118","author":"Pooladgar","year":"2023","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2026100710014733800_fcag364-B45","doi-asserted-by":"crossref","first-page":"26818","DOI":"10.1038\/s41598-025-09772-8","article-title":"A randomized comparative feasibility study of neuromodulation and cognitive training for post-COVID fatigue","volume":"15","author":"Oliver-Mas","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"2026100710014733800_fcag364-B46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12868-025-00989-x","article-title":"Modulating subjective and objective cognitive state fatigue in long COVID with repetitive anodal tDCS: Results from a double-blinded randomized controlled trial","volume":"27","author":"Mischke","year":"2026","journal-title":"BMC Neurosci"},{"issue":"1","key":"2026100710014733800_fcag364-B47","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1038\/s41598-023-32779-y","article-title":"Effects of repetitive twice-weekly transcranial direct current stimulations on fatigue and fatigability in people with multiple sclerosis","volume":"13","author":"Linnhoff","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"2026100710014733800_fcag364-B48","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41380-026-03471-0","article-title":"Circulating mitochondrial and cellular damage markers in long COVID: Links to cognitive function, psychological distress, and inflammation","volume":"31","author":"Matits","year":"2026","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2026100710014733800_fcag364-B49","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s11357-024-01398-4","article-title":"Novel biomarkers of mitochondrial dysfunction in long COVID patients","volume":"47","author":"Sz\u00f6gi","year":"2025","journal-title":"Geroscience"},{"issue":"6","key":"2026100710014733800_fcag364-B50","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1007\/s12035-024-04471-3","article-title":"A gene cluster of mitochondrial complexes contributes to the cognitive decline of COVID-19 infection","volume":"62","author":"Xu","year":"2025","journal-title":"Mol Neurobiol"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcag364\/71437428\/fcag364.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/5\/fcag364\/71437428\/fcag364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/5\/fcag364\/71437428\/fcag364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:01:58Z","timestamp":1791381718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcag364\/8841135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcag364","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"fcag364"}}